Close Menu

NEW YORK (GenomeWeb) – Bruker said today it has signed a definitive agreement to acquire a majority interest in infectious disease molecular diagnostics firm Hain Lifescience.

According to Bruker, Nehren, Germany-based Hain will add capabilities in tuberculosis and mycobacteria testing, as well as virology and human genetics.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.